Phenytoin Levels Should Be Measured; Levetiracetam Levels Are Not Routinely Necessary
In patients on both Keppra (levetiracetam) and Dilantin (phenytoin), you need to measure serum phenytoin levels, but routine levetiracetam level monitoring is generally not indicated.
Phenytoin (Dilantin) Monitoring
Phenytoin levels must be monitored because this drug exhibits saturable (non-linear) pharmacokinetics and has a narrow therapeutic window 1. The therapeutic range is typically 10-20 mcg/mL, though toxicity manifestations vary considerably between individuals 2, 1.
When to Check Phenytoin Levels:
- After loading doses: Therapeutic levels (≥10 mg/L) are achieved within minutes after IV infusion completion, but follow-up monitoring on an outpatient basis remains important 2
- At steady state: Wait at least 5-7 half-lives (7-10 days minimum) after treatment initiation, dosage changes, or addition/subtraction of interacting drugs before checking levels 1
- With clinical concerns: Check levels when assessing for toxicity (nystagmus appears around 20 mcg/mL, ataxia at 30 mcg/mL, dysarthria/lethargy >40 mcg/mL) or suspected non-compliance 1
- During dose adjustments: Because phenytoin metabolism is saturable at high serum levels, small incremental dose increases (even 10%) can produce disproportionately large increases in serum levels and cause intoxication 1
Critical Phenytoin Monitoring Pitfall:
Phenytoin is highly protein-bound, so free phenytoin levels may be more informative in patients with hypoalbuminemia, renal disease, or hepatic disease where protein binding is altered 1. Total levels can be misleadingly low in these situations while free (active) drug remains therapeutic or toxic.
Levetiracetam (Keppra) Monitoring
Levetiracetam levels do NOT require routine monitoring 3. This drug has several pharmacokinetic advantages:
- Linear, predictable dose-concentration relationship
- Minimal protein binding (<10%) 3
- No significant cytochrome P450 interactions 3
- Broad therapeutic window with no established correlation between levels and efficacy or toxicity 4
When Levetiracetam Monitoring MAY Be Considered:
While not routine, therapeutic drug monitoring of levetiracetam can be useful in specific populations with altered pharmacokinetics 4:
- Critically ill patients: May have augmented clearance requiring higher doses
- Pregnancy: Levels decline as pregnancy progresses due to increased GFR
- Pediatric patients: Clearance increased by 30-40% compared to adults
- Elderly patients: Clearance decreased by approximately 50% in patients >65 years
- Renal impairment: Clearance declines linearly with creatinine clearance 4, 5
- Suspected non-compliance or breakthrough seizures despite adequate dosing
Important Drug Interaction Note:
Phenytoin co-administration increases levetiracetam clearance by approximately 22-43% 6, 5. However, this interaction is moderate and generally does not require dose adjustment 7. Levetiracetam does not affect phenytoin levels 3, 7.
Practical Monitoring Algorithm
For your patient on both medications:
- Monitor phenytoin levels routinely (at steady state, with dose changes, and when clinically indicated)
- Do NOT routinely monitor levetiracetam levels unless the patient falls into a special population (critically ill, pregnant, extremes of age, renal dysfunction) or has unexplained treatment failure
- Be aware that enzyme-inducing properties of phenytoin may modestly increase levetiracetam clearance, but this rarely necessitates intervention 6, 5
- If checking phenytoin levels in patients with hypoalbuminemia or organ dysfunction, consider requesting free phenytoin levels for more accurate assessment 1